FRIEDLI PETER

CIK 00010083173 companiesCOLUMBIA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001008317

Recent Transactions

32 trades

Disposition to Issuer
OSIRIS THERAPEUTICS, INC.
Common Stock
2019-04-17$19.00/sh−10,204,404→ 0 total
Disposition to Issuer
OSIRIS THERAPEUTICS, INC.
Common Stock
2019-04-17$19.00/sh−4,103,301→ 0 total
Disposition to Issuer
OSIRIS THERAPEUTICS, INC.
Common Stock
2019-04-17$19.00/sh−500,000→ 0 total
Disposition to Issuer
OSIRIS THERAPEUTICS, INC.
Common Stock
2019-04-17$19.00/sh−2,750→ 0 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2014-02-06$14.93/sh+10,000→ 10,204,404 total
Other
OSIRIS THERAPEUTICS, INC.
Common Stock
2014-01-17+0→ 4,606,051 total
Tax Payment
OSIRIS THERAPEUTICS, INC.
Common Stock
2013-08-14$25.44/sh−432,390→ 10,194,404 total
Exercise/Conversion
OSIRIS THERAPEUTICS, INC.
Common Stock
2013-08-14$11.00/sh+1,000,000→ 10,626,794 total
Exercise/Conversion
OSIRIS THERAPEUTICS, INC.
Common Stock Purchase Warrant
2013-08-14−1,000,000→ 0 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2013-02-12$7.73/sh+10,000→ 9,626,794 total
Sale
OSIRIS THERAPEUTICS, INC.
Common Stock
2012-12-10$9.52/sh−50,000→ 4,606,051 total
Sale
OSIRIS THERAPEUTICS, INC.
Common Stock
2012-11-15$9.34/sh−625→ 4,656,051 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2012-03-23$5.08/sh+10,000→ 9,616,794 total
Gift
OSIRIS THERAPEUTICS, INC.
Common Stock
2011-12-06$4.87/sh−500,000→ 9,606,794 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2011-02-14$7.13/sh+10,000→ 10,106,794 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2009-02-23$18.60/sh+10,000→ 4,166,685 total
Purchase
OSIRIS THERAPEUTICS, INC.
Convertible Promissory Note
2008-03-24$12.17/sh+2,500,000→ 1,205,423 total
Other
OSIRIS THERAPEUTICS, INC.
Common Stock
2008-02-04+29,741→ 9,870,371 total
Gift
OSIRIS THERAPEUTICS, INC.
Common Stock
2008-02-04$12.01/sh−1,000→ 9,841,630 total
Award
OSIRIS THERAPEUTICS, INC.
Common Stock
2008-02-04$12.01/sh+10,000→ 4,974,245 total
Purchase
OSIRIS THERAPEUTICS, INC.
Common Stock
2007-12-19$12.37/sh+100,000→ 9,174,884 total
Exercise/Conversion
OSIRIS THERAPEUTICS, INC.
Promissory Note
2007-12-19$13.00/sh−472,222→ 1,000,000 total
Purchase
OSIRIS THERAPEUTICS, INC.
Common Stock
2007-12-19$13.00/sh+662,746→ 9,837,630 total
Purchase
OSIRIS THERAPEUTICS, INC.
Convertible Promissory Note
2007-06-06$18.00/sh+4,000,000→ 1,472,222 total
Purchase
OSIRIS THERAPEUTICS, INC.
Common Stock
2007-06-06$11.38/sh+1,230,229→ 9,074,884 total
Other
OSIRIS THERAPEUTICS, INC.
Common Stock
2007-05-11+37,381→ 7,844,655 total
Purchase
INVENDA CORP
Series C Preferred Stock
2005-06-24$4.00/sh+125,000→ 3,239,986 total
Purchase
INVENDA CORP
Series C Preferred Stock
2005-04-26$4.00/sh+250,000→ 3,114,986 total
Purchase
INVENDA CORP
Series C Preferred Stock
2005-04-19$4.00/sh+125,000→ 2,864,986 total
Award
INVENDA CORP
Common Stock
2005-02-22+100,000→ 29,432,861 total
Award
VANTAGEMED CORP
Option to purchase VantageMed common stock
2004-08-03$0.60/sh+20,000→ 146,000 total
Award
VANTAGEMED CORP
option to purchase common stock
2003-09-22$0.21/sh+20,000→ 126,000 total

Companies

Recent Filings

Address

C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE

COLUMBIA, MD, 21046

View on SEC.gov